Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell.
Biotechnology company Athersys Inc. (Nasdaq: ATHX) of Cleveland announced it plans to sell more than 19.8 million common shares for $1.01 per share.
The company expects to collect $20 million in gross proceeds from the public offering, which is set to close by Wednesday, Feb. 1. The company’s stock at 2:10 p.m. on Monday, Jan. 30, was trading at $1.15 per share.
Click here to read the complete article.
Originally published January 30, 2017.